登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
C6H5CH2CH2CH[NHCOOC(CH3)3]COOH
化学文摘社编号:
分子量:
279.33
UNSPSC Code:
12352202
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
3653506
产品名称
Boc-Homophe-OH, ≥98.0% (TLC)
InChI
1S/C15H21NO4/c1-15(2,3)20-14(19)16-12(13(17)18)10-9-11-7-5-4-6-8-11/h4-8,12H,9-10H2,1-3H3,(H,16,19)(H,17,18)/t12-/m0/s1
SMILES string
CC(C)(C)OC(=O)N[C@@H](CCc1ccccc1)C(O)=O
InChI key
MCODLPJUFHPVQP-LBPRGKRZSA-N
assay
≥98.0% (TLC)
form
powder
optical activity
[α]20/D +6.5±1°, c = 2% in ethanol
reaction suitability
reaction type: Boc solid-phase peptide synthesis
mp
76-80 °C
application(s)
peptide synthesis
storage temp.
2-8°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
法规信息
新产品
此项目有
R Voegeli et al.
International journal of cosmetic science, 39(2), 109-120 (2016-07-20)
The aim of this study was to optimize the synthesis of the plasmin and urokinase (uPA) inhibitor benzylsulfonyl-D-Ser-homoPhe-(4-amidino-benzylamide) (BSFAB), to characterize its activity and mechanism of action and to assess its use to improve stratum corneum (SC) barrier function. Peptide
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持